Our findings indicated Tim-3+ NKT cells have a trend to express more CD147 and CD26 in COVID-19 patients, which might suggest Tim-3+ NKT subset cells are highly susceptible to SARS-CoV-2 infection. This evidence concerns the gene BSG and COVID-19.